Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hologic, Inc. - Common Stock (NQ:HOLX)

74.06 +0.15 (+0.20%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hologic, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
15 16 Next >
Hologic to Expand Outreach During Breast Cancer Awareness Month
From Hologic, Inc.
Via Business Wire
Nanaz Mohtashami Elected to Hologic Board of Directors
From Hologic, Inc.
Via Business Wire
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. 
Via Benzinga
Analyst Expectations for Hologic's Future
 
Via Benzinga
Hologic's Earnings: A Preview
 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Hologic to Webcast Presentations at Upcoming Investor Conferences
From Hologic, Inc.
Via Business Wire
Hologic Stock Falls After Q3 Revenue Dip, But It Lifts Revenue and Profit Outlook
Hologic Inc (NASDAQ: HOLX) posted Q3 adjusted EPS of $0.93, down from $0.95 a year ago and beating the consensus of $0.88 
Via Benzinga
Hologic Announces Financial Results for Third Quarter of Fiscal 2023
From Hologic, Inc.
Via Business Wire
Expert Ratings for Hologic
 
Via Benzinga
What 9 Analyst Ratings Have To Say About Hologic
 
Via Benzinga
Earnings Preview For Hologic
 
Via Benzinga
Earnings Scheduled For July 31, 2023
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million. 
Via Benzinga
3 Top Analyst Picks Worth Your Attention Now
These top analyst picks, offering robust upside ahead, represent a beacon amidst the stock market chaos at this time. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
 
Via Benzinga
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2023 on Monday, July 31, 2023
From Hologic, Inc.
Via Business Wire
Illumina Takes AI to Genomics: Launch of PrimateAI-3D for Accurate Disease Prediction
Illumina, Inc. (NASDAQ: ILMN) launched PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients. 
Via Benzinga
Hologic Announces FDA Clearance of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay
From Hologic Inc.
Via Business Wire
Time To Play Small Cap Life Science Stocks
The overall market sentiment has been hit hard by MACRO concerns. The dominating narrative is the Fed and the Debt Ceiling. 
Via Talk Markets
A New Groundbreaking Tool to Detect Colon Cancer Earlier
A novel blood test for detecting colon cancer, the third most lethal type of cancer in the US, has been created. The Colorectal Cancer Screening Blood Test can identify cancer at early stages. This... 
Via PressReach
Hologic Announces Partnership with NFL Rookie Kelee Ringo and Family
From Hologic Inc.
Via Business Wire
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review
The major indexes retreated for most of the week on banking fears, 
Via Investor's Business Daily
Hologic to Webcast Presentation at the BofA Securities 2023 Healthcare Conference
From Hologic, Inc.
Via Business Wire
Can Butterfly Network Spread its Wings in 2023?
Butterfly Network Inc. (NYSE: BFLY) is a medical imaging solutions company that makes point-of-demand portable ultrasound devices to bring medical imaging to h 
Via MarketBeat
Topics Artificial Intelligence
Hologic Announces Financial Results for Second Quarter of Fiscal 2023
From Hologic, Inc.
Via Business Wire
Earnings Scheduled For May 1, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2023 on Monday, May 1, 2023
From Hologic, Inc.
Via Business Wire
Biotech And Life Science Trades: Q1 2023 Performance By The Numbers
Despite a strong month and a great finish to the quarter, many traders remain cautious about the market. It’s been a volatile time after the collapse of Silicon Valley Bank, but the first quarter of... 
Via Talk Markets
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer
FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 24, 2023 – USA News Group – Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs... 
Via FinancialNewsMedia
Hologic to Webcast Presentation at the Cowen 43rd Annual Health Care Conference
From Hologic, Inc.
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.